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Abstract:  
 Cocaine addiction is a brain disorder that affects millions of people and generates 
enormous social and economic costs to society. The continuous potential for relapse during 
periods of withdrawal makes treatment of cocaine addiction especially difficult. These studies 
investigate the molecular mechanisms mediating relapse behavior in a rodent model of cocaine 
addiction. Recent studies have demonstrated that AMPA glutamate receptor-dependent synaptic 
plasticity in the nucleus accumbens (NAc) core plays a critical role in cocaine seeking. It is 
unclear, however, how dopamine receptor signaling interacts with NAc AMPA receptors to 
mediate this behavior. Here, we investigate the interaction between dopamine and AMPA 
receptors in the nucleus accumbens and explore how adenosine receptor stimulation may 
counteract dopamine receptor-induced cocaine seeking and modulation of AMPA receptor 
trafficking. Specifically, we tested whether stimulating adenosine A1 or A2A receptors in the NAc 
could reduce dopamine D1 or D2, respectively, receptor-induced reinstatement. We also 
determined whether stimulating A1 or A2A receptors in the NAc would reduce D1 or D2 receptor-
induced changes in synaptic GluR1 phosphorylation using a synaptoneurosome preparation and 
subsequent immunoblot analyses. As a correlate to these studies, we used viral-mediated gene 
transfer to determine the effects of expressing a GluR1S845A phosphomutant (Ser 845 Ala) in 
the NAc on cocaine, D1, and D2-induced reinstatement.  Our results demonstrate that stimulation 
of A1 receptors decreases D1-induced cocaine seeking and GluR1S845 phosphorylation. 
Stimulation of A2A receptors both increases GluR1S845 phosphorylation and decreases D2-
induced cocaine seeking and GluR1 internalization. Interestingly, overexpressing the GluR1S845A 
phosphomutant in the NAc significantly reduced D2, but not D1 or cocaine-induced 
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reinstatement. These findings suggest that adenosine receptors act to offset dopamine receptor-
mediated modulation of AMPA receptor trafficking that drives cocaine seeking. 
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Introduction: 
 Treatment of cocaine addiction is especially difficult because of the constant potential for 
relapse in addicts during periods of abstinence. Research in humans and animal models has 
shown that the mesolimbic dopamine system is a key neural circuit involved in drug seeking 
behaviors (Shaham et. al, 2003, Shalev et. al, 2002). The mesolimbic dopamine system consists 
of dopamine cells in the ventral tegmental area that project to the nucleus accumbens (NAc) 
among other forebrain targets. Activation of this pathway contributes to the initial euphoria 
associated with drug taking, while re-activation of this pathway through stress exposure, drug-
associated cues, and pharmacological stimuli plays a role in drug relapse during abstinence  
(Shaham et. al, 2003). Identifying molecular mechanisms that contribute to mesolimbic 
dopamine system re-activation during abstinence will provide insight into the dysregulation of 
neurotransmitter systems that occurs during addiction. Furthermore, characterization of the 
signaling events relevant to relapse may elucidate novel targets to offset drug-induced 
perturbations to these systems. 
 Two prominent rodent models of cocaine addiction are locomotor sensitization and the 
self-administration/reinstatement procedure (Robinson and Berridge, 2008, Shaham et. al, 2003). 
In the locomotor sensitization model, rodents exhibit enhanced (sensitized) locomotor responses 
to repeated daily injections of cocaine. Enhanced locomotor activity persists after periods of drug 
withdrawal whereby subsequent administration of cocaine or other pharmacological stimuli 
induces expression of sensitized responses to the treatment (Thomas et. al, 2008). It is thought 
that the development and expression of locomotor sensitization reflects neurobiological 
perturbations in the mesolimbic dopamine system resulting from continuous injections of 
cocaine (Thomas et. al, 2008, Kalivas et. al, 1998). 
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 In the self-administration/reinstatement model, rodents are trained to perform a lever-press 
response to receive intravenous infusions of cocaine (DeVries et. al, 1999). Rodents are placed in 
an operant conditioning chamber for daily self-administration sessions, during which active 
(drug-paired) lever presses are reinforced with cocaine infusions. Both active and inactive lever 
presses are recorded, but inactive lever presses have no effect. Following approximately 3 weeks 
of daily self-administration sessions, rodents then undergo extinction training to abolish lever-
pressing behavior. During this phase, rodents are placed in the operant conditioning chamber for 
daily extinction sessions during which responses at the previously drug-paired (active) lever no 
longer produce cocaine reinforcement. After lever responses are significantly abolished, rodents 
are placed back in the operant conditioning chamber where drug seeking (active lever pressing) 
is reinstated by drug-paired cues, cocaine injection, or other pharmacological stimuli. 
Reinstatement of cocaine seeking models the persistent potential for relapse in addicts, and 
indicates that dysregulation of the mesolimbic dopamine pathway persists long into periods of 
abstinence from drug use (DeVries et. al, 1999, Shaham et. al, 2003). In these studies, we seek to 
enhance understanding of how the neurotransmitters glutamate, dopamine, and adenosine 
interact within the NAc to regulate cocaine sensitization and cocaine seeking behavior. 
 The initial rewarding properties of cocaine are largely due to blockade of dopamine, 
norepinephrine, and serotonin transporters, causing increased extracellular concentrations of 
these neurotransmitters (Ritz et. al, 1990). Increased dopamine neurotransmission in the NAc is 
critical to the development and expression of behavioral sensitization, the acquisition of cocaine 
self-administration, and reinstatement of cocaine seeking (Di Chiara, 1995, Koob, 2009, Self and 
Nestler, 1998).  Five subtypes of dopamine receptors are stimulated by cocaine-induced 
enhancements in dopamine neurotransmission, including the D1-like receptor family consisting 
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of D1 and D5 receptors, and the D2-like receptor family consisting of D2, D3, and D5 receptors 
(Missale et. al, 1998, Sibley et. al, 1993). D1 receptors are metabotropic receptors that enhance 
adenylyl cyclase activity through GαS coupling (Missale et. al, 1998), leading to increased cyclic 
adenosine monophosphate (cAMP) formation and protein kinase A (PKA) activity (Sibley et. al, 
1993). Conversely, D2 receptors are coupled to Gαi/o proteins and inhibit adenylyl cyclase, 
cAMP formation, and PKA activity (Sibley et. al, 1993).  In rodent models of cocaine 
sensitization and self-administration, stimulation of either dopamine D1 or D2 receptors in the 
NAc core is sufficient to induce expression of cocaine sensitization as well as cocaine seeking 
following extinction training (Bachtell et. al, 2005, DeVries et. al, 1999, Self et. al, 1996, Dias et. 
al, 2004, Ujike et. al, 1990). It has become increasing clear, however, that dopamine receptors 
play a modulatory role on glutamate neurotransmission in the NAc.  
 Glutamate is the major excitatory neurotransmitter of the central nervous system and is 
critical to learning and memory processes (Anggono and Huganir, 2008). Glutamate input into 
the NAc from the hippocampus, prefrontal cortex, and amygdala is involved in cocaine 
sensitization and reinstatement of drug seeking (Kalivas et. al, 2005, Kalivas and Hu, 2006). 
Glutamate input is mediated by (±)-α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid 
(AMPA) receptors, which are ligand-gated ion channels that cause rapid, post-synaptic 
depolarization (Anggono and Huganir, 2008). AMPA receptors play a critical role in multiple 
forms of synaptic plasticity that underlie learning and memory (Anggono and Huganir, 2008, 
Malenka and Nicoll, 1999). Long-term potentiation (LTP) is a model of synaptic plasticity where 
trafficking of AMPA receptors to the postsynaptic density increases synaptic strength and 
excitatory glutamate neurotransmission (Malenka and Nicoll, 1999). Long-term depression 
(LTD), on the other hand, is also a model of synaptic plasticity where internalization of AMPA 
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receptors from the cell surface decreases synaptic strength and excitatory glutamate 
neurotransmission (Traynelis et. al, 2010). AMPA receptor-based plasticity alters the excitability 
of NAc neurons throughout cocaine administration (Hyman et. al, 2006), and acute stimulation 
of AMPA receptors in the NAc following chronic cocaine administration induces both locomotor 
sensitization and reinstatement of cocaine seeking (Cornish et. al, 1999, Cornish and Kalivas, 
2000, Bachtell et. al, 2008). Cocaine administration during withdrawal produces locomotor 
sensitization and induces reinstatement, both of which are also mediated by AMPA receptor 
stimulation (Cornish et. al, 1999, Pierce et. al, 1996, Bell et. al, 2000). Thus, administration of 
cocaine during withdrawal produces a rapid increase in glutamate release in the NAc that 
enhances AMPA-mediated glutamate transmission and is thought to be critical for locomotor 
sensitization and cocaine-induced reinstatement (Bell and Kalivas, 1996, 2000, Bachtell et. al 
2008). Recent studies suggest that cocaine modulates AMPA-receptor trafficking through 
phosphorylation of the GluR1 subunit, and that AMPA-receptor trafficking in the NAc is 
necessary for cocaine-induced reinstatement and expression of cocaine sensitization (Anderson 
et al., 2008, Bachtell et. al, 2008).  However, the contribution of metabotropic dopamine receptor 
signaling to AMPA-receptor trafficking in the NAc is unclear, especially in the modulation of 
cocaine-related behaviors. 
Recent work suggests that dopamine and glutamate receptors interact to produce behavioral 
changes, although the mechanisms of these interactions are not clear. Thus, modulating AMPA-
receptor activity in the NAc by viral gene transfer alters behavioral responses to cocaine as well 
as dopamine receptor agonists (Bachtell et al., 2008a, Bachtell et al., 2008b). AMPA receptors 
containing the GluR1 subunit are especially prone to activity-dependent receptor trafficking. The 
GluR1 subunit contains multiple phosphorylation sites that regulate GluR1-containing AMPA 
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receptor trafficking and insertion into post-synaptic spines (Anggono and Huganir, 2008, Lee et. 
al, 2003, Lee et. al, 2010).  Of particular interest are two serine residues, 845 and 831 
(GluR1S845/S831) that are phosphorylated by PKA and Ca2+/calmodulin-dependent protein kinase 
II (CaMKII), respectively (Lee et. al, 2010, Malenka and Nicoll, 1999).  Since D1 receptor 
stimulation increases, while D2 receptor stimulation decreases PKA activity, GluR1S845 
phosphorylation in the NAc may play a critical role in AMPA-receptor based plasticity that 
directly regulates the expression of cocaine sensitization and cocaine seeking. Identifying 
strategies to offset glutamate signaling and dopamine receptor modulation of glutamate signaling 
in the NAc will provide greater insight into the factors contributing to relapse as well as reveal 
novel therapeutic targets. 
 Adenosine is a purine nucleoside and neuromodulator that antagonizes dopamine signaling 
in the NAc through stimulation of adenosine A1 or A2A receptors expressed on NAc medium 
spiny GABAergic neurons (MSNs; Ferre et. al, 1992, 1999, Filip et. al, 2012, Svenningson, 
1999b). MSNs comprise approximately 90-95% of all NAc neurons and exist in two main 
populations characterized by distinct peptide expression, receptor expression and projection 
targets (Aubert et. al, 2000, Steiner and Gerfen, 1998).  MSNs of the direct pathway express 
dynorphin, postsynaptic D1 and A1 receptors and project primarily to the ventral tegmental area, 
while MSNs of the indirect pathway express enkephalin, postsynaptic D2 and A2A receptors and 
project to the ventral pallidum (Lu et. al, 1998). Co-localization of A1 receptors with D1 
receptors allows adenosine to regulate dopamine signaling within direct pathway MSNs, since 
stimulation of A1 receptors activates inhibitory G-proteins that oppose D1-induced activation of 
adenylyl cyclase and cAMP formation (Ferre et. al, 1997, 1999, Dunwiddie and Masino, 2001). 
Similarly, stimulation of A2A receptors on indirect pathway neurons opposes D2 receptor 
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signaling by activating stimulatory G-proteins that enhance adenylyl cyclase activity and cAMP 
formation (Schiffman et. al, 2007, Svenningson et. al, 1999a, Tozzi et. al, 2007, Dunwiddie and 
Masino, 2001, Ferre et. al, 1994). 
There has been recent interest in the unique contributions that these two populations of 
MSNs contribute to drug addiction. For example, it is thought that repeated cocaine 
administration produces enhanced signaling through the direct pathway neurons that promotes 
drug seeking, while simultaneous reducing activity in the indirect pathway neurons that oppose 
drug seeking (Lobo and Nestler, 2011). Therefore, we are interested in exploring how NAc A1 
receptors may reduce the extent to which D1 receptor-mediated enhancements of the direct 
pathway drive drug-seeking behaviors. We are also interested in how NAc A2A receptors may 
reduce D2 receptor-mediated inhibition of the indirect pathway to restore inhibitory control. We 
have recently demonstrated that stimulation of NAc A1 or A2A receptors blocks the expression of 
cocaine sensitization, suggesting that adenosine receptor stimulation might reduce dopamine 
receptor-mediated reinstatement of cocaine seeking (Hobson et. al, 2012).  The purpose of these 
studies was to 1) characterize how both D1- and D2-receptor signaling interacts with AMPA 
receptor activity in the NAc to regulate reinstatement of cocaine seeking in rats, 2) determine 
whether stimulation of adenosine receptors offsets dopamine receptor-mediated reinstatement, 
and 3) determine whether adenosine receptor stimulation offsets dopamine receptor-mediated 
changes in GluR1 phosphorylation. 
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Methods: 
Animals and Housing Conditions 
Male Sprague–Dawley rats (Charles River, Wilmington, MA) weighing 275–325 g were 
individually housed with ad libitum food and water. All experiments were conducted during the 
light period of a (12:12) light/dark cycle in accordance with the guidelines established by the 
Institutional Animal Care and Use Committee at the University of Colorado at Boulder. 
General Locomotor Sensitization Procedure 
Locomotor activity was recorded in plexiglass chambers (San Diego Instruments, San Diego, 
CA, USA) measuring 16 × 16 × 15 inches with 16 pairs of photobeams spaced 1 inch apart on 
both the x- and y-axes. All locomotor tests were performed in darkened chambers during the light 
phase of the light:dark cycle. Animals were initially habituated to the locomotor testing 
chambers for 2-h the day prior to start of the sensitization procedure. Cocaine (15 mg/kg, i.p.) 
injections were performed daily for one week and horizontal locomotor activity was assessed in 
the activity monitoring chambers. Locomotor sensitization criteria was defined as Day 7 cocaine-
induced activity > Day 1 cocaine-induced locomotor activity. 
Surgery 
For all self-administration experiments, jugular catheters and intracranial cannulae were 
sequentially implanted during the same surgery under halothane anesthesia (1–2.5%). First, 
catheters were implanted into the jugular vein according to previously published procedures 
(O’Neill et al., 2011).  Each rat was then placed into a stereotaxic instrument, the scalp was 
incised and retracted, and the head was positioned with bregma and lambda at the same depth 
coordinate. Screws were secured into the skull and holes were drilled in order to bilaterally insert 
guide cannulae into the NAc core (A/P: +1.7; M/L: +/−1.5; D/V: −5.7 from bregma; Paxinos and 
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Watson, 1998). Once inserted, the guide cannulae were fixed in place with dental cement. 
Dummy stylets extending 1 mm beyond the tip of the cannulae were placed into the guide 
cannulae to maintain patency. Catheters were flushed daily with 0.1 ml heparinized saline and 
rats were allowed 7 days recovery in their home cage before experimental procedures began. For 
experiment 3 (cocaine sensitization), only intracranial cannulae were implanted by the same 
procedure described above.  
Cocaine Self-Administration and Extinction Procedures 
Self-administration procedures were performed in operant conditioning chambers (Med-
Associates, St Albans, VT) equipped with two response levers and an infusion pump system. 
Animals were initially trained to lever press for sucrose pellets to facilitate acquisition of cocaine 
self-administration. After 24–48 h of food restriction, rats were trained to lever press for sucrose 
pellets on a fixed ratio 1 (FR1) reinforcement schedule until acquisition criteria were achieved 
(100 sucrose pellets in one session). After lever-press training, animals were fed ad libitum for at 
least 1 day before surgery (see above). After recovery from surgery, animals were allowed to 
self-administer intravenous cocaine (0.5 mg/kg/100 µl jugular catheter infusion) on an FR1 
reinforcement schedule in daily 4-h sessions for 5-6 days per week. Cocaine infusions were 
delivered over 5 s concurrent with the illumination of a cue light above the active lever.  The 
infusion and cue light were followed by a 15 s time-out period during which the house light 
remained off and responding produced no consequence. Inactive lever responses produced no 
consequence throughout testing. After a minimum of 15 cocaine self-administration sessions, 
animals returned to the operant conditioning chambers for extinction training. Extinction 
sessions occurred in the absence of cocaine reinforcement in 4-h test sessions. Responses on the 
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lever previously paired with cocaine injections during self-administration (active lever) and on 
the inactive lever were recorded, but had no programmed drug or cue delivery. 
Reinstatement Procedures 
Each reinstatement session was initiated with 2 h of extinction conditions, followed by a 2 h 
reinstatement test period. For experiments involving viral vector infusion to the NAc, 
reinstatement testing occurred during the peak of viral expression (see below). Drug 
microinfusions were administered to the NAc after the 2-h extinction period, and were followed 
by the 2-h reinstatement test period (see below). Responses at both the previously drug-paired 
and inactive levers were recorded, but resulted in no cue or drug delivery during testing. 
Microinjections and Histology 
Drug microinfusions (1 µl/side over 60 s) were delivered through bilateral 33 gauge injectors 
extending 1 mm beyond the guides. The microinjectors were removed 1 min after the full 
infusion volume was given to ensure absorption into the tissues. In these experiments, 
reinstatement was assessed over repeated sessions and animals received a maximum of four 
treatments in a randomized/counter-balanced order. Herpes simplex viral (HSV) vectors 
encoding mutant GluR1S845A, and LacZ (expressing ß-galactosidase as a control) were produced 
and administered as described previously (Carlezon et al., 1997; Neve et al., 1997; Sutton et al., 
2003).  Viral vectors were infused 2-3 days after extinction training and reinstatement testing 
occurred 24-96 h after virus was infused to the NAc, which is consistent with the previously 
established time course of viral expression (Bachtell et al., 2008, Sutton et al., 2003). Following 
behavioral testing (excluding experiments involving tissue collection for immunoblotting, see 
below), localization of infusion sites was determined by infusing 0.5 µl of cresyl violet dye in 
anesthetized animals and analyzed in 0.8 mm thick coronal slices under a dissecting microscope. 
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Experiment 1: Effects of A2A stimulation on cocaine naïve animals 
This experiment tested the effects of acute systemic administration of the A2A agonist CGS 
21680 (0.03 mg/kg, i.p.) on cocaine naïve animals.  Injections of CGS 21680 or saline were 
administered 30 minutes prior to sacrifice and tissue collection. Tissue punches were 
homogenized as whole cell lysates (no fractionation) for subsequent immunoblotting analyses 
(see below). 
Experiment 2: Effects of A2A stimulation on cocaine challenge in cocaine sensitized animals 
This experiment tested the effects of a systemic cocaine challenge (15 mg/kg, i.p.) in the 
presence or absence of the A2A agonist CGS 21680 (0.03 mg/kg, i.p.) in cocaine sensitized 
animals. After cocaine locomotor sensitization and one week of withdrawal (see above), animals 
received a pretreatment of vehicle or CGS 21680 followed by a challenge of vehicle or cocaine. 
Thirty minutes after the challenge treatment, animals were sacrificed and tissues were collected. 
Tissue punches were homogenized as whole cell lysates (no fractionation) for subsequent 
immunoblotting analyses (see below). 
Experiment 3: Effects of A2A stimulation on a quinpirole (D2 agonist) challenge in cocaine 
sensitized animals 
This experiment tested the effects of intra-NAc administration of quinpirole (3.0 µg/side) in 
the presence or absence of the A2A agonist CGS 21680 (2.5 ng/side) in cocaine sensitized 
animals. After cocaine locomotor sensitization and one week of withdrawal (see above), animals 
received an intra-NAc pretreatement of vehicle or CGS 21680 followed by an intra-NAc 
treatment of vehicle or quinpirole. Pre-treatments were administered 5 minutes prior to the 
treatment of quinpirole or saline. Thirty minutes after treatment, animals were sacrificed and 
infusion sites were verified under a dissection microscope. Tissue punches were then collected 
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and homogenized as whole cell lysates (no fractionation) for subsequent immunoblotting 
analyses (see below). 
Experiment 4: Effects of A2A stimulation on D2-induced reinstatement and GluR1 
Phosphorylation and Expression 
This experiment tested the effects of intra-NAc adenosine A2A receptor stimulation on intra-
NAc D2-induced reinstatement. Following a 2-hr extinction period, intra-NAc infusions of 
vehicle, the D2 agonist quinpirole (3.0 µg/side), CGS 21680 (2.5 ng/side) or the co-infusion of 
quinpirole and the A2A agonist CGS 21680 were administered. A 2-hr reinstatement test was 
performed immediately following the intra-NAc infusion. Twenty-four hrs following the 
reinstatement test, the same intra-NAc treatment was administered, and tissue from the infusion 
site was collected 30 min post-treatment for synaptoneurosome fractionation and subsequent 
immunoblotting analyses (see below). 
Experiment 5: Effects of A1 stimulation on D1-induced reinstatement and GluR1 Phosphorylation 
and Expression 
This experiment tested the effects of intra-NAc adenosine A1 receptor stimulation on intra-
NAc D1-induced reinstatement. Following a 2-hr extinction period, intra-NAc infusions of 
vehicle, the D1 agonist SKF 81297 (3.0 µg/side), or the co-infusion of SKF 81297 (3.0 µg/side) 
and the A1 agonist CPA (1.5 µg/side) were administered. A 2-hr reinstatement test was 
performed immediately following the intra-NAc infusion. Twenty-four hrs following the 
reinstatement test, the same intra-NAc treatment was administered, and tissue from the infusion 
site was collected 30 min post-treatment for synaptoneurosome fractionation and subsequent 
immunoblotting analyses (see below). 
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Experiment 6: Effects of Intra-NAc GluR1S845A Phosphomutant on D1, D2, and cocaine -induced 
reinstatement 
This experiment tested the effects PKA-phospho mutant GluR1S845A, and LacZ viral 
expression in the NAc on intra-NAc dopamine D1-mediated reinstatement (SKF 81297), intra-
NAc dopamine D2-mediated reinstatement (quinpirole), and cocaine reinstatement. Following 
extinction training animals were counterbalanced according to cocaine self-
administration/extinction responding and administered an HSV vector encoding GluR1S845A or 
LacZ. Twenty-four hrs following HSV infusion, reinstatement was induced by infusing SKF 
81297 (3.0 µg/side) into the NAc, infusing quinpirole (3.0 µg/side) into the NAc, or by cocaine 
injection (15 mg/kg, i.p.).  Treatments occurred after the 2-hr extinction period, and were 
immediately followed by the 2-hr reinstatement period. Each rat was tested across the three 
treatments in a randomized order. 
Tissue collection, Synaptoneurosome Preparation, and Immunoblotting 
For all experiments involving immunoblotting, rats underwent rapid decapitation and brain 
dissection.  Brains were sliced into 1.0 mm thick coronal sections using ice-cold razor blades and 
a brain matrix (Braintree Scientific Inc, Braintree, MA). For experiments 1 and 2 (no intracranial 
cannulae), the brain regions of interest were collected using bilateral 12-gauge tissue punches. 
For experiments 3-5, the infusion site was first verified under a dissecting microscope, and 
bilateral 12-gauge tissue punches were performed directly surrounding the infusion site. Infusion 
sites located outside the NAc were excluded from behavioral and immunoblot analyses. Tissue 
punches from non-infused dorsal striatum were also collected as a site control. For experiments 
1-3 (no fractionation), tissue punches were immediately homogenized by sonication in lysis 
buffer. 
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For experiments 4 and 5, tissue punches were mechanically minced with a glass dounce 
homogenizer in 50µL homogenization buffer (HB: 1M Tris, 1M Sucrose, 0.5M EDTA, 0.25M 
EGTA, 0.5M NaF, 1M benzamidine, 100mM AEBSF) containing phosphatase and protease 
inhibitor cocktails (Sigma-Aldrich, St. Louis, MO).  The tissue was then subjected to a 
synaptoneurosome preparation protocol previously described (Cortese et al., 2011). Once the 
synaptic (P2) fraction was obtained and homogenized in HB (same as above, but containing 1x 
STE buffer), synaptic enrichment of the P2 fraction was confirmed by probing for GluR1 and 
post-synaptic density protein 95 (PSD95), common synaptic markers. Protein content was 
quantified using the Lowry protein (BioRad, Hercules, CA, USA). 
Samples were prepared under reducing conditions in 4x Laemmli buffer and heated at 70°C 
for 10 minutes. Protein samples (15µg) were loaded onto 4–12% NuPage Bis-Tris SDS-
polyacrylamide gels (Invitrogen, Grand Island, NY) and transferred onto Immobilon-FL PVDF 
membranes (Millipore, Billerica, MA, USA). Membranes were blocked in 5% bovine serum 
albumin (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) in tris-buffered saline with 
0.1% tween (TBST) for 1 hour at room temperature. Membranes were incubated with primary 
antibody (see below) at 4°C overnight followed by 3 × 15 minute TBST washes. Membranes 
were then incubated with appropriate secondary antibodies at room temperature for 1 hour, 
washed and detected by enhanced chemiluminescence (Super Signal West Dura, Thermo 
Scientific) for experiments 1-3, or by a Licor Odyssey infrared scanning device for experiments 
4 and 5. All images were converted to gray-scale and quantified using Odyssey densitometry 
software. The following primary antibodies were all obtained from Millipore and used at 
dilutions of 1:1000, except where noted: Tubulin isoform beta III (MAB1637, 1:2500), Total 
GluR1 (MAB2263), Phospho-GluR1-Serine 831 (04-823), Phospho-GluR1-Serine 845 
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(AB5849), and PSD95 (MABN68). Primary antibodies for Total ERK (p44/42 MAPK, Cat. 
#4695, 1:2000) and Phospho-ERK Thr202/Tyr204 (Phospho-p44/42 MAPK, Cat. #9106, 
1:2000) were obtained from Cell Signaling. Secondary antibodies conjugated to horseradish 
peroxidase were purchased from Millipore and used at a dilution of 1:25,000 in 5% non-fat dried 
milk/TBST. Secondary antibodies conjugated to infrared dyes were purchased from Licor 
(Lincoln, NE) and were used at a dilution of 1:15,000 in 5% BSA/TBST. For multiple detections 
of the same blot, blots were stripped using Restore Western Blot Stripping Buffer (Pierce, 
Rockford, IL) for 20 minutes and washed 3 × 15 minutes in TBST and subjected to standard 
immunoblotting conditions. 
Drugs 
The D1 receptor agonist, SKF 81297 ((±)-6-Chloro-PB hydrobromide), the D2-selective 
agonist, quinpirole ((−)-quinpirole hydrochloride), and cocaine hydrochloride were obtained 
from Sigma Aldrich (St. Louis, MO). The A1 receptor agonist, CPA (N6-cyclopentyladenosine) 
and the A2A agonist, CGS 21680, were obtained from Tocris Bioscience (Ellisville, MO). All 
drugs were dissolved in sterile-filtered physiological (0.9%) saline or physiological PBS (pH 
7.4). 
Data analysis 
The numbers of animals in each experimental group ranged from 8 to 16 and are reported for 
each experiment in the table/figure captions. All reinstatement data (dependent variables: active 
lever and inactive lever responses) were analyzed by a two-way ANOVA with lever (within) and 
treatments (between) as the factors unless otherwise noted. Significant interactions were 
followed up with simple main effects analyses (one-way ANOVA) and post hoc tests 
(Bonferroni's comparisons). Immunoblotting data from experiment 1 was analyzed with an 
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unpaired t-test. Immunoblotting data for all other experiments was analyzed by one-way 
ANOVA with treatment group as the factor. Significant interactions were followed up with post 
hoc tests (Dunnett’s comparisons). Statistical significance was set at p < 0.05 for all tests. 
 	   	  
	   	   Hobson	   20	  
Results 
Experiment 1: Acute A2A receptor stimulation has no effect on phosphorylation of GluR1 or ERK 
in the striatum of cocaine naïve animals 
Adenosine receptors can regulate dopamine receptor signaling in both dorsal motor and 
ventral reward striatal pathways (Ferre et. al, 1992, 1997). We recently demonstrated that 
pharmacological stimulation of A2A receptors in the NAc inhibits sensitized locomotor responses 
and cocaine mediated reinstatement of cocaine seeking (O’Neill et. al, 2011, Hobson et al. 2012). 
We therefore sought to determine the mechanisms involved in these behavioral changes.  We 
first explored how acute A2A stimulation would increase protein kinase A-mediated 
phosphorylation of GluR1 in the striatum of cocaine naïve animals. We also measured 
phosphorylation of extracellular-signal-regulated kinase (ERK, or p42/44 MAP kinase) to 
determine whether A2A receptors might activate the mitogen-activated-protein kinase pathway, a 
canonical signaling pathway often activated by G-protein coupled receptors (Zhai et. al, 2008). 
We collected tissue 30 minutes after a single injection of the A2A agonist CGS 21680 (0.03 
mg/kg, i.p.) or saline and analyzed pGluR1S845 and pERK in the NAc core, NAc shell, and the 
dorsal striatum.  Table 1 shows that administration of CGS 21680 had no effect on either 
pGluR1S845 or phospho-ERK in any of the brain regions analyzed. These findings are not 
surprising since intra-NAc A2A stimulation did not affect acute locomotor sensitivity to cocaine, 
suggesting that behaviorally relevant doses of the A2A agonist CGS 21680 may not significantly 
effect striatal signaling in cocaine naïve animals (Hobson et. al, 2012). 
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Table 1: Effects of Acute CGS 21680 on Cocaine Naïve Animals 
Protein Brain Region Saline (n=4) CGS (n=4) Statistics 
pERK / 
tERK 
NAc Shell 100.0 ± 6.22 90.7 ± 3.87 t(14)=1.28, p=0.22 
    
NAc Core 100.0 ± 2.84 101.5 ± 5.14 t(14)<1, NS 
    
DS 100.0 ± 3.07 96.2 ± 4.65 t(14)<1, NS 
     
     
pGluR1S845 / 
tGluR1 
NAc Shell 100.0 ± 1.92 103.2 ± 4.42 t(14)<1, NS 
    
NAc Core 100.0 ± 2.05 101.6 ± 3.32 t(14)<1, NS 
    
DS 100.0 ± 1.17 94.8 ± 2.93 t(6)=1.66, p=0.15 
CGS 21680 (0.03 mg/kg, i.p.) was administered 30 minutes prior to sacrifice and tissue collection. Values are 
% (mean ± sem) of saline control for phospho/total protein ratio. NAc= Nucleus Accumbens, DS= Dorsal 
Striatum, NS= Not significant. pERK residues are T202 and Y204. 
 
Experiment 2: A2A receptor stimulation does not inhibit cocaine-induced GluR1S845 
phosphorylation in the striatum of cocaine-sensitized animals 
We have recently demonstrated that intra NAc A2A stimulation, either by CGS 21680 or by 
elevating concentrations of endogenous adenosine, blocks both cocaine and D2-induced 
expression of cocaine sensitization (Hobson et. al, 2012). We therefore tested whether A2A 
receptor stimulation might offset cocaine-induced changes in signaling within the NAc core and 
shell of cocaine-sensitized animals. Following 7 daily injections of cocaine and 7 days of 
withdrawal, we administered a challenge injection of either saline or cocaine (15 mg/kg, i.p.) 
following a pretreatment of either vehicle or CGS 21680 (0.03 mg/kg, i.p.). We collected tissue 
30 minutes after treatment and analyze pGluR1S845 and pERK in the NAc core and shell. Figure 
1a shows that the average locomotor activity of the animals is greater on Day 7 than on Day 1, 
indicating behavioral sensitization (t30 = 1.26, p = 0.022). A significant main effect of treatment 
on pGluR1S845 in the NAc core was observed (F3,14 = 4.49, p = 0.027) where cocaine increased 
pGluR1S845 approximately 25% relative to saline controls in the NAc core (Figure 1b, p = 
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0.0654). This effect was not altered by a pretreatment of CGS 21680 (p < .05).  CGS 21680 
alone had no effect on pGluR1S845 in the NAc core as was observed in the cocaine-naïve animals. 
Figure 1c shows that no treatment had any significant effect on pGluR1S845 in the NAc shell 
(F3,15=0.38, p = 0.77). Table 2 shows that no treatment had any significant effect on pERK in 
either NAc shell or core. 
 
 
 
 
 
 
 
 
Figure 1: Intra-NAc core administration of the adenosine A2A agonist CGS 21680 does not 
alter cocaine-induced GluR1S845 phosphorylation in cocaine-sensitized animals.  
(a) Animals display locomotor sensitization over 7 days of repeated cocaine injections. (b) 
Systemic administration of cocaine increased pGluR1S845 in the NAc core regardless of pre-
treatment with the A2A CGS 21680 or vehicle. (c) None of the treatments administered caused 
significant changes in pGluR1S845 in the NAc shell. *Significant from Sal/Sal (p < .05 
Bonferroni’s post-test), #Significant trend from Sal/Sal (p = .0654 Bonferroni’s post-test) 
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Table 2: Effects of Acute Cocaine/CGS 21680 on Cocaine Sensitized Animals 
Protein Brain Region 
Sal/Sal 
(n=4) 
Coc/Sal  
(n=4) 
Coc/CGS 
(n=4) 
Sal/CGS 
(n=4) Statistics 
pERK / 
tERK 
NAc Shell 100.0 ± 5.11 112.2 ± 8.00 118.8 ± 4.34 99.59 ± 6.81 F(3,12)=2.30, p=0.130 
      
NAc Core 100.0 ± 4.18 107.7 ± 3.62 104.5 ± 5.14 94.85 ± 8.64 F(3,10)=1.09, p=0.397 
       
       
pGluR1S845 
/ tGluR1 
NAc Shell 100.0 ± 8.18 95.72 ± 3.89 105.2 ± 6.48 97.50 ± 7.37 F(3,12)=0.385, p=0.766 
      
NAc Core 100.0 ± 7.80 ^125.8 ± 3.63 *129.7 ± 5.89 107.6 ± 8.33 F(3,11)=4.49, p=0.027 
^Significant trend from Sal/Sal (p=.0654), *Significant from Sal/Sal, p<.05 
CGS (0.03 mg/kg, i.p.) or saline was administered as a pre-treatment 5 minutes prior to cocaine (15 mg/kg, 
i.p.) or saline.  Sacrifice and tissue collection occurred 30 minutes after cocaine or saline treatment. Values 
are reported as % of saline control for phospho/total protein ratio. NAc= Nucleus Accumbens. pERK residues 
are T202 and Y204. 
 
 
Experiment 3: Intra-NAc A2A receptor stimulation increases GluR1S845 phosphorylation in 
cocaine-sensitized animals 
Cocaine increases extracellular dopamine that nonselectively stimulates both D1 and D2 
receptors (Ritz et. al, 1990). We hypothesized that cocaine-induced increases in NAc core 
pGluR1S845 are likely mediated by the GαS-coupled D1 receptors present in direct pathway 
medium spiny neurons. Since adenosine A2A receptors are coupled to GαS proteins and oppose 
D2-induced inhibition of cAMP signaling on the postsynaptic terminals of indirect pathway 
medium spiny neurons (Ferre et. al, 1997), it seems that A2A receptor stimulation might inhibit 
cocaine sensitization and cocaine seeking by counteracting D2-signaling within these cells. 
Therefore, we tested whether intra-NAc A2A stimulation might offset D2-induced changes in 
pGluR1S845 or pERK in the NAc core of cocaine-sensitized animals using. Figure 2a shows that 
the average locomotor activity of the animals is greater on Day 7 than on Day 1, indicating 
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behavioral sensitization (t32=3.23, p < .01). A significant effect of intra-NAc core treatment on 
pGluR1S845 (F3,26 = 4.33, p = 0.013) and pERK (F3,26 = 7.35, p = 0.001) was observed.  
 
 
 
 
 
 
 
 
 
Figure 2: Intra-NAc core administration of the adenosine A2A agonist CGS 21680 increases 
GluR1S845 phosphorylation in cocaine-sensitized animals.  
(a) Animals display locomotor sensitization over 7 days of repeated cocaine injections. (b) Intra-
NAc core infusion of the A2A agonist CGS 21680 significantly increases pGluR1S845 in the NAc 
core. (c) Intra-NAc core pre-treatment with the A2A agonist CGS 21680 followed by infusion of 
the D2 agonist quinpirole significantly increases pERK in the NAc core. Neither agonist alone 
has a significant effect on pERK. *Significant from Sal/Sal (p < .05 Bonferroni’s post-test), 
**Significant from Sal/Sal (p < .01 Bonferroni’s post-test) 
 
Intra-NAc core administration of CGS 21680 alone increased pGluR1S845 approximately 30% 
relative to saline controls (Figure 2b, p < .05). Intra-NAc quinpirole produced a small decrease in 
pGluR1S845, although this was not statistically significant (t16 = 1.273, p = 0.22).  Infusion of 
both quinpirole and CGS 21680 had no effect on pGluR1S845 (p > .05). Figure 2c shows neither 
quinpirole nor CGS 21680 alone had a significant effect on pERK relative to saline control (p > 
.05). Infusion of both quinpirole and CGS 21680 increased pERK approximately 35% (p < .05). 
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Experiment 4A: Stimulation of A2A receptors impairs D2-induced cocaine seeking 
We have previously shown that stimulation or blockade of NAc A2A receptors inhibits or 
enhances, respectively, cocaine-seeking behavior elicited by systemic administration of the D2 
agonist quinpirole (O’Neill et. al, 2011). In order to identify the potential mechanism by which 
intra-NAc A2A receptor stimulation acts to inhibit D2-mediated reinstatement, we administered 
infusions of quinpirole (3.0 µg/side) or saline in the presence of either CGS 21680 (2.5 ng/side) 
or vehicle into the medial NAc core prior to reinstatement testing. As expected, intra-NAc 
quinpirole significantly induced reinstatement, which was blocked by simultaneous A2A receptor 
stimulation (Figure 3). A significant interaction between lever and treatment (F3,51 = 4.20; p = 
0.0099) and a main effect of treatment (F3,51 = 8.42; p = 0.0001) were observed. Post-hoc tests 
(Bonferroni’s) revealed animals that received quinpirole alone significantly reinstated (p < .001), 
while those that received quinpirole and CGS 21680 did not reinstate compared to control 
animals (p > .05). 
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Experiment 4B: Stimulation of A2A receptors increases GluR1S845 phosphorylation and modestly 
impairs D2-mediated GluR1 Internalization 
Previous studies have shown that modulation of AMPA receptor function by overexpressing 
wild-type or dominant negative GluR1 in the NAc core modulates cocaine sensitization and 
reinstatement of cocaine seeking induced by cocaine and a D2 agonist (Bachtell et. al, 2008). 
Since intra-NAc core A2A stimulation blocks intra-NAc core D2-mediated reinstatement (Figure 
3), we sought to determine whether A2A receptor stimulation in the NAc core might alter D2-
induced alterations in GluR1 expression and/or phosphorylation. One day after reinstatement 
testing, we administered infusions of quinpirole and/or CGS 21680 as described in experiment 
4A. Thirty minutes after treatment, animals were sacrificed and tissues from the NAc core 
(infusion site) and dorsal striatum were subjected to a synaptoneurosome fractionation protocol 
to isolate a synaptic fraction (P2) and a cytosolic fraction (S2). As shown in Figure 4, the 
synaptoneurosome preparation produces an enrichment of PSD 95 and total GluR1 (tGluR1) in 
the P2 fraction, while the S2 fraction is enriched in ß-tubulin. Tissue samples were 
immunoblotted to analyze PKA phosphorylation at serine 845 (pGluR1S845) and CaMKII/PKC 
phosphorylation at serine 831 (pGluR1S831). Phosphorylation at these residues has been shown to 
be critical for activity-dependent AMPA receptor synaptic trafficking (Malenka and Nicoll, 
1999, Lee, 2006, Shepherd and Huganir, 2007).  
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Figure 4: Synaptoneurosome fractionation protocol and representative immunoblot of 
tissue from NAc core and dorsal striatum. 
15 µg of protein from P2 (synaptic) and S2 (cytosolic) fractions were loaded into each lane. Note 
that synaptic proteins (tGluR1 and PSD 95) are enriched in the P2 fraction, while cytosolic 
protein (β-tubulin) is enriched in the S2 fraction. For all subsequent experiments, PSD 95 and β-
tubulin were used as loading controls for the P2 and S2 fractions, respectively. 
 
A significant effect of treatment on tGluR1 expression levels (F3,28 = 5.67, p = 0.0036) and 
pGluR1S845 (F3,28 = 7.08, p = 0.0011) in the NAc core P2 fraction was observed. Figure 5 shows 
representative immunoblots of the NAc core P2 fraction. Quinpirole alone decreased expression 
of tGluR1 by 35% (p < .05), while quinpirole and CGS 21680 together decreased tGluR1 by 
only 23%, which was not significantly different from control (p > .05). The differences between 
quinpirole alone and the combination of quinpirole and CGS 21680 were also not significantly 
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different (p > .05). CGS 21680 alone had no effect on tGluR1 (p > .05). Quinpirole had no effect 
on pGluR1S845 alone or in the presence of CGS 21680 (p > .05), while CGS 21680 increased 
pGluR1S845 by 47% (p < .01). No significant effect of treatment was observed for pGluR1S831 in 
the NAc core P2 fraction (F3,28 = 2.28, p = 0.1011). Quinpirole produced approximately 30% 
increases in pGluR1S831 when administered alone or in the presence of CGS 21680, however, 
these effects were not statistically significant (p > .05). Similar analyses in the NAc core S2 
fraction and dorsal striatum P2 fraction showed no differences in tGluR1 levels or GluR1 
phosphorylation (Table 3). 
 
 
 
 
 
 
 
Figure 5: Intra-NAc core administration of the adenosine A2A agonist CGS 21680 increases 
GluR1S845 phosphorylation and modestly blocks D2 agonist-induced internalization of 
synaptic GluR1.  
(a) Intra-NAc core infusion of the D2 agonist quinpirole alone significantly decreases tGluR1 
levels in the P2 fraction. Quinpirole does not significantly decrease tGluR1 levels in the P2 
fraction when co-administered with the A2A agonist CGS 21680 (b) Intra-NAc core infusion of 
the D2 agonist quinpirole alone or together with the A2A agonist CGS 21680 modestly increases 
pGluR1S831 in the P2 fraction, however these effects are not statistically significant. (c) Intra-
NAc core infusion of the A2A agonist CGS 21680 significantly increases pGluR1S845 in the P2 
fraction. *Significant from Sal/Sal (p < .05 Bonferroni’s post-test), **Significant from Sal/Sal (p 
< .01 Bonferroni’s post-test) 
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Table 3: Effects of Acute Intra-NA Core Quinpirole/CGS 21680 on Cocaine Self-
Administering Animals 
Protein Brain Region 
Sal/Sal 
(n=4) 
Quin/Sal  
(n=4) 
Quin/CGS 
(n=4) 
Sal/CGS 
(n=4) Statistics 
tGluR1 /  
ß-Tubulin 
NAc 
Core S2 100.0 ± 19.2 90.5 ± 10.09 111.5 ± 12.38 108.2 ± 19.5 
F(3,21)=0.385, 
p=0.765 
       
tGluR1 / 
PSD 95 DS P2 100.0 ± 11.0 138.9 ± 30.39 87.1 ± 3.76 113.5 ± 15.8 
F(3,11)=1.25, 
p=0.338 
       
pGluR1S831
/ tGluR1 
DS P2 100.0 ± 2.66 99.5 ± 6.98 98.9 ± 6.60 99.9 ± 4.10 F(3,12)=0.009, p=0.999 
       
pGluR1S845
/ tGluR1 
DS P2 100.0 ± 3.70 104.1 ± 13.46 108.3 ± 11.75 110.1 ± 9.23 F(3,12)=0.195, p=0.898 
CGS 21680 (2.5 ng/side) and/or quinpirole (3.0 µg/side) were bilaterally infused in 1 µl of saline over a 
period of 1 minute.  Sacrifice and tissue collection occurred 30 minutes after intracranial infusions treatment. 
Values are reported as % of saline control for phospho/total protein ratio. NAc= Nucleus Accumbens, DS= 
Dorsal Striatum. 
 
Experiment 5A: Stimulation of A1 receptors impairs D1-induced cocaine seeking  
 Adenosine A1 receptors are coupled to inhibitory G proteins and oppose D1-induced 
enhancements in cAMP signaling on the postsynaptic terminals of direct pathway medium spiny 
neurons in the NAc (Ferre et. al, 1997, Dunwiddie and Masino, 2001). Thus, adenosine A1 
receptors may be a prime target for inhibiting D1-mediated behaviors. We have recently shown 
that, like A2A receptor stimulation, stimulation of A1 receptors in the NAc also reverses the 
expression of cocaine sensitization (Hobson et al., 2012). Preliminary evidence suggests that A1 
receptor stimulation also reduces reinstatement of cocaine seeking (unpublished observations). 
To test the effects of A1 receptor stimulation on D1-induced reinstatement, we administered intra-
NAc infusions of the D1 agonist SKF 81297 (3.0 µg/side) alone or in concert with the A1 
receptor agonist, CPA (0.1 µg/side). Figure 6 shows that A1 receptor stimulation significantly 
reduced D1-induced reinstatement. A significant interaction (F2,22 = 8.38; p = 0.0313) and main 
effects of treatment (F2,22 = 62.00; p < 0.0001) and of lever (F1,22 = 6.12; p = 0.0232) were 
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observed. Post-hoc analysis (Bonferroni’s) revealed animals that received SKF 81297 alone 
significantly reinstated (p < .01), while those that received SKF 81297 and CPA did not (p > 
.05). 
 
 
 
 
 
 
 
 
 
 
 
Experiment 5B: Stimulation of A1 receptors offsets D1-mediated GluR1 Phosphorylation 
 We have previously shown that AMPA receptor function is necessary for D1-mediated 
reinstatement (unpublished observations) and A1 receptor stimulation inhibits D1-mediated 
reinstatement (Figure 6). We therefore hypothesized that A1 receptor stimulation offsets D1-
induced PKA activity that contributes to GluR1-containing AMPA receptor trafficking. To test 
this hypothesis, we collected tissue from the NAc core and dorsal striatum 30 minutes after intra-
NAc core infusion of SKF 81297 or the combination of CPA and SKF 81297 (treatments same 
as in Experiment 5A and given 24 hrs after reinstatement testing). Tissue samples were 
processed as in Experiment 4B (synaptoneurosome preparation) and immunoblotted to analyze 
GluR1 expression and phosphorylation as in Experiment 4B.  
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Figure 6: Intra-NAc core 
administration of the adenosine A1 
agonist CPA blocks D1 agonist-
induced reinstatement of cocaine 
seeking.  
Intra-NAc core infusion of the D1 
agonist SKF 81297 significantly 
induces reinstatement, while co-
administration of the D1 agonist SKF 
81297 and the A1 agonist CPA has no 
significant effect. ** Significant from 
Sal/Sal (p < .01 Bonferroni’s post-
test) 	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Figure 7: Intra-NAc core administration of the adenosine A1 agonist CPA blocks D1 agonist-
induced phosphorylation of GluR1S845.  
(a) Intra-NAc core infusion of the D1 agonist SKF 81297 alone or in the presence of the A1 
agonist CPA has no effect on tGluR1 levels in the P2 fraction. (b) Intra-NAc core infusion of the 
D1 agonist SKF 81297 and the A1 agonist CPA together significantly increases pGluR1S831, 
while SKF 81297 alone has no effect in the P2 fraction. (c) Intra-NAc core infusion of the D1 
agonist SKF 81297 significantly increases pGluR1S845 in the P2 fraction, which is reversed by 
co-administration of the A1 agonist CPA. *Significant from Sal/Sal (p < .05 Bonferroni’s post-
test), **Significant from Sal/Sal (p < .01 Bonferroni’s post-test) 
 
Figure 7 shows representative immunoblots of the NAc core P2 fraction of samples collected 
30 minutes after vehicle, SKF 81297, or SKF 81297/CPA co-administration. There was no 
significant difference between groups in tGluR1 levels in the NAc core P2 fraction (F2,28  = 1.13; 
p = 0.34). A significant effect of treatment was observed for pGluR1S845 (F2,29 = 4.09; p = .0273) 
and pGluR1S831 (F2,28 = 8.73; p= 0.0011) in the NAc core P2 fraction. Treatment of SKF 81297 
alone increased pGluR1S845 by 99% (p < .05), while this effect was completely reversed by co-
administration of CPA (p > .05). Treatment with CPA/SKF 81297 together increased pGluR1S831 
by 65% (p < .01), while treatment with SKF 81297 alone had no significant effect on pGluR1S831 
(p > .05). Similar analyses in the NAc core S2 fraction and dorsal striatum P2 fraction showed no 
differences in tGluR1 levels or GluR1 phosphorylation (Table 4). 
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Table 4: Effects of Acute Intra-NA Core SKF 81297/CPA on Cocaine Self-Administering 
Animals 
Protein Brain Region 
Sal/Sal 
(n=6) 
SKF/Sal 
(n=5) 
SKF/CPA  
(n=5) Statistics 
tGluR1 /         
ß-Tubulin NAc Core S2 100.0 ± 14.38 105.8 ± 3.62 110.0 ± 9.69 
F(3,21)=0.385, 
p=0.765 
tGluR1 /     
PSD 95 
DS P2 100.0 ± 6.95 120.7 ± 5.32 
 
105.4 ± 10.53 
 
F(2,12)=1.836, 
p=0.216 
pGluR1S831/ 
tGluR1 
DS P2 100.0 ± 5.35 105.7 ± 5.47 
 
124.0 ± 15.56 
 
F(2,12)=1.56, 
p=0.249 
pGluR1S845 / 
tGluR1 
DS P2 100.0 ± 2.39 123.1 ± 20.23 
 
95.45 ± 17.18 F(2,13)=1.021, 
p=0.387 
SKF 81297 (3.0 µg/side) or SKF and CPA (1.5 µg/side) were bilaterally infused in 1 µl/side over 1 minute.  
Sacrifice and tissue collection occurred 30 minutes after intracranial infusions treatment. Values are reported 
as % of saline control for phospho/total protein ratio. NAc= Nucleus Accumbens, DS= Dorsal Striatum. 
 
Experiment 6: Expression of mutant GluR1S845 inhibits D2, but not D1 or cocaine-induced 
reinstatement 
Recent work has shown that GluR1-containing AMPA receptor trafficking plays a critical 
role in cocaine seeking (Bachtell et al., 2009, Anderson et al., 2008), and that this trafficking 
may be modulated by NAc core dopamine receptor signaling (Anderson et al., 2008, Figures 4B 
and 5B). Based on these results, we hypothesized that D1 or D2 receptor-induced reinstatement 
may be mediated by increases or decreases, respectively, in synaptic GluR1 that result from 
changes in pGluRS845. To directly test the involvement of GluR1S845 phosphorylation in 
reinstatement, we tested the effects of overexpressing the GluR1 subunit with a serine to alanine 
mutation at serine 845 (GluR1S845A) in the NAc core, on cocaine, D2, and D1-induced cocaine 
seeking. Following extinction of lever pressing, herpes simplex virus (HSV) vectors expressing 
either GluR1S845A or Lac Z (ß-gal expressing control) were infused into the NAc core. Two to 
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four days following administration of viral vectors, cocaine seeking was induced by systemic 
administration of cocaine (15 mg/kg, i.p.) or by intra-NAc infusion of the D1 agonist SKF 81297 
(3.0 µg/side) or the D2 agonist quinpirole (3.0 µg/side). Figure 8 shows that GluR1S845A 
expression in the NAc had no effect on cocaine-induced reinstatement (t10 = 0.25; p = 0.81). For 
intra-NAc elicited reinstatement, a significant effect of virus was observed (F1,20 = 8.92; p = 
0.0073). GluR1S845A significantly reduced quinpirole-induced cocaine seeking compared to LacZ 
expressing controls (t = 2.69; p < .05), while GluR1S845A only slightly reduced SKF 81297-
induced reinstatement (t = 1.54; p > .05). 
 
 
 
 
 
 
 
 
 
 
Figure 8: Intra-NAc core expression of GluR1 mutant GluR1S845A blocks quinpirole-induced 
reinstatement.  
(a) Expression of GluR1S845A significantly blocked D2 agonist-induced reinstatement. GluR1S845A 
slightly reduced D1 agonist-induced reinstatement, however, this effect was not statistically 
significant. (b) Expression of GluR1S845A has no effect on cocaine-induced reinstatement. 
*Significant from LacZ (p < .05 Bonferroni’s post-test)	  
 
 
 
S
K
F 
81
29
7
Q
ui
np
iro
le
0
50
100
150
200
LacZ
GluR1S845A
Intra-NAc treatment
A
c
ti
v
e
 L
e
v
e
r 
P
re
s
s
e
s
 (
2
 h
rs
)
LacZ GluR1S845A
0
50
100
150
200
A
c
ti
v
e
 L
e
v
e
r 
P
re
s
s
e
s
 (
2
 h
rs
)
*
a
Cocaine (15 mg/kg, i.p.)
b
	   	   Hobson	   34	  
Discussion: 
 Recent studies have shown that stimulation of adenosine receptors inhibits multiple cocaine-
related behaviors such as locomotor sensitization and reinstatement (Filip et. al, 2006, Bachtell 
et. al, 2009) but the molecular mechanisms underlying these effects remain unclear. In these 
studies, we investigated how adenosine A1 and A2A receptor stimulation might offset dopamine 
D1 and D2 receptor signaling, respectively, in NAc neurons to regulate cocaine-seeking behavior. 
Given the importance of AMPA receptor-based plasticity in both cocaine- and dopamine agonist-
induced locomotor sensitization and reinstatement (Bachtell et. al, 2008a, Cornish et. al, 1999, 
Cornish and Kalivas, 2000), we specifically investigated whether dopamine and adenosine 
receptors might exert opposing actions on PKA-mediated phosphorylation of GluR1S845. 
 Emerging evidence suggests that adenosine receptors may play a critical role in neurological 
conditions involving hyper- and hypo-dopaminergic signaling in the striatum, such as 
Parkinson’s disease, Huntington’s disease, and psychostimulant addiction (Ferre et. al, 1997, 
1999). However, several reports indicate that stimulation of adenosine receptors does not 
significantly alter behavioral responses to enhanced dopamine signaling in healthy, drug naïve 
animals (Filip et. al, 2006, Poleszak and Malec, 2002). For example, we recently demonstrated 
that stimulation of A1 or A2A receptors in the NAc core blocks the expression of cocaine 
sensitization, but has no effect on cocaine-induced locomotor activity in cocaine naïve animals 
(Hobson et. al, 2012). Consistent with these results, we found that systemic administration of the 
A2A agonist CGS 21680 has no effect on either pGluR1S845 or pERK in the striatum. However, in 
cocaine-sensitized animals, intra-NAc core administration of CGS 21680 significantly increased 
pGluR1S845. These results suggest that repeated exposure to cocaine might cause perturbations 
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enabling adenosine receptor stimulation to affect intracellular signaling and cellular excitability 
in the NAc core. 
 Although it is clear that stimulation of NAc core adenosine receptors can modulate 
behaviors associated with repeated cocaine exposure, a clear mechanism for these effects has not 
been established. Here, we pharmacologically stimulated adenosine receptors to investigate 
adenosine receptor-mediated signaling and potential changes in GluR1S845 phosphorylation 
during cocaine-induced expression of locomotor sensitization. Based on the distinct expression 
of D1 and D2 receptors on NAc MSNs, and their opposing actions on PKA activity, we 
hypothesized that cocaine-induced non-selective stimulation of dopamine receptors 
simultaneously causes increases in pGluR1S845 in D1-expressing cells of the direct pathway and 
decreases in pGluR1S845 in D2-expressing cells of the indirect pathway. This notion is supported 
by findings suggesting that repeated cocaine administration enhances the excitability of direct 
pathway neurons, while decreasing the excitability of indirect pathway neurons (Lobo and 
Nestler, 2011). We found that cocaine significantly increased pGluR1S845 in whole cell lysates 
from the NAc core of cocaine-sensitized animals, an effect that was not reversed by A2A receptor 
stimulation.  Since D2 receptors inhibit, while D1 receptors enhance PKA activity, cocaine-
induced increases in pGluR1S845 most likely occur in direct pathway neurons. This idea is 
consistent with the fact that stimulation of A2A receptors, localized on D2-expressing indirect 
pathway neurons, does not reverse cocaine-induced pGluR1S845. It seems that in the present 
experiment, D1-mediated increases in pGluR1S845 occurring in direct pathway neurons mask our 
ability to observe any D2 or A2A receptor-mediated changes in pGluR1S845 occurring in indirect 
pathway neurons. 
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To directly test the hypothesis that A2A receptor-mediated reversal of D2-induced deficits in 
pGluR1S845 plays a role in blocking cocaine and D2 agonist-induced expression of locomotor 
sensitization, we directly stimulated D2 and/or A2A receptors in the NAc core of cocaine-
sensitized animals. Quinpirole alone produced a modest, non-significant decrease in pGluR1S845 
in whole cell lysates from the NAc core, while CGS 21680 alone significantly increased 
pGluR1S845. These results correlate with the behavioral effects of A2A receptor stimulation on D2 
agonist-induced expression of locomotor sensitization and support the idea that NAc core A2A 
receptors offset D2-induced deficits in PKA activity (Hobson et al, 2012). Furthermore, the fact 
that intra-NAc CGS 21680 induces pGluR1S845 suggests that A2A receptors may restore cocaine-
induced deficits in cellular excitability of indirect pathway neurons. Interestingly, co-
administration of quinpirole and CGS 21680 significantly increased pERK in the NAc core of 
cocaine-sensitized animals, while either agonist alone produced slight, non-significant increases. 
This result may be caused by additive activation of the MAP kinase pathway by the beta/gamma 
subunits of both G-protein coupled receptors, which are known to modestly increase MAP kinase 
signaling independently (Zhai et. al, 2008). 
We recently demonstrated that stimulation of NAc core A2A receptors blocks reinstatement 
induced by systemic administration of both cocaine and a D2 agonist (O’Neill et. al, 2011). To 
determine whether pGluR1S845 is also relevant to the inhibitory effects of A2A receptor 
stimulation on reinstatement, we explored whether changes in pGluR1S845 during reinstatement 
testing might parallel those observed during expression of sensitization. Our results show that 
reinstatement induced by stimulation of NAc core D2 receptors was reversed by A2A receptor 
stimulation, consistent with our hypothesis that A2A receptors oppose D2 signaling within NAc 
core indirect pathway MSNs. D2 receptor stimulation significantly decreased synaptic levels of 
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total GluR1 in the NAc core. This effect was modestly blunted by simultaneous A2A stimulation. 
Again, A2A stimulation alone significantly increased pGluR1S845 in the NAc core. Recent work 
suggests that in addition to regulating trafficking to the cell surface, GluR1S845 phosphorylation 
is critical for maintaining the stability of GluR1-containing AMPA receptors within the 
postsynaptic density (Lee et al., 2004, 2006). Thus, D2 receptor stimulation may act to reduce 
excitatory neurotransmission in indirect pathway neurons by diminishing PKA-mediated 
phosphorylation and facilitating removal of synaptic AMPA receptors. Stimulation of NAc core 
A2A receptors, on the other hand, may act to offset D2-induced deficits in pGluR1S845, 
internalization of AMPA receptors, and decreased excitability of indirect pathway MSNs, 
ultimately blocking cocaine and D2-mediated reinstatement. 
A recent study proposed a similar, but distinct mechanism of cocaine reinstatement involving 
D1 receptor-mediated enhancements of GluR1 trafficking to the postsynaptic density of direct 
pathway MSNs (Anderson et. al, 2008). Functionally, enhanced AMPA receptor trafficking in 
direct pathway neurons would promote behavioral activation, such as the expression of cocaine 
sensitization and cocaine reinstatement. Consistent with the idea that offsetting D1-induced PKA 
activity might inhibit GluR1S845 phosphorylation that is necessary for reinstatement, we recently 
showed that intra-NAc core A1 receptor stimulation blocks the expression of sensitization to 
cocaine (Hobson et. al, 2012). Indeed, intra-NAc core A1 receptor stimulation inhibits D1-
induced reinstatement and reverses D1-induced increases in pGluR1S845. These results are 
supported by findings suggesting that AMPA receptor activity is necessary for D1-induced 
reinstatement (unpublished observations). Taken together, these findings suggest that stimulation 
of NAc core A1 receptors inhibits D1-induced reinstatement through a potential mechanism 
	   	   Hobson	   38	  
where A1 receptors inhibit D1-induced increases in pGluR1S845, thereby reducing D1-mediated 
enhancements in synaptic AMPA receptors and excitability of direct pathway neurons. 
 However, there are several discrepancies between our results and those previously reported 
by Anderson et. al (2008). Most striking is the fact that Anderson et. al did not observe an 
increase in NAc pGluR1S845 following systemic administration of 10 mg/kg cocaine. We 
observed a 25% increase in pGluR1S845 following 15 mg/kg cocaine. While the difference in 
dosing may be important here, other findings are still discrepant. For example, they report a 
cocaine-induced increase in pGluR1S831, which was attributed to activation of CaMKII, an effect 
blocked by D1 receptor antagonism. These results are seemingly at odds with our findings that 
both cocaine and D1 receptor stimulation increased pGluR1S845, while D1 receptor stimulation 
alone did not increase pGluR1S831. Since phosphorylation of GluR1 serines 845 and 831 are both 
thought to mediate insertion of AMPA receptors into the postsynaptic density (Malenka and 
Nicoll, 1999, Lee et. al, 2004), these differing results seem to support the same basic mechanism. 
However, it appears that systemic administration of cocaine, which influences multiple 
neurotransmitter systems throughout the brain, causes different cellular responses compared with 
local infusion of a D1 agonist into the NAc. Thus, this methodological difference may account 
for some of the discrepancy between our findings. Future studies will shed light on the specific 
role of GluR1 serines 845 and 831 in cocaine and D1-mediated reinstatement. 
 It is also interesting to note that in our studies, simultaneous stimulation of A1 and D1 
receptors significantly increased pGluR1S831. Unfortunately, we did not treat animals with A1 
agonist alone, so we cannot determine whether this effect is mediated by A1 stimulation alone or 
by combined stimulation of A1 and D1 receptors. It is possible that this effect, like our finding 
that simultaneous stimulation of D2 and A2A receptors increases pERK, is mediated by additive 
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activation of the MAP kinase pathway by both G-protein coupled receptors (Zhai et. al, 2004). 
Another possibility is that the increased pGluR1S831 is a compensatory response due to the 
inhibition of GluR1S845 phosphorylation produced by A1 receptor stimulation. This idea is 
supported by studies of phosphomutant transgenic mice with mutations at GluR1 serine 845, 
831, or both (Lee et. al, 2010). Mice mutant for both residues cannot develop LTP, while 
mutation of either residue alone has no significant effect on the development and maintenance of 
LTP, suggesting that these residues can compensate for each other (Lee et. al, 2010). However, 
others have shown that PKA activity is necessary for CaMKII driven insertion of AMPA 
receptors into synapses (Esteban et. al, 2003).  This may explain why the putatively 
compensatory GluR1S831 phosphorylation in animals treated with the A1 agonist was not able to 
compensate for pGluR1S845 in facilitating D1-induced reinstatement behavior. 
 These studies also provide insight into our finding that expression of the GluR1S845A 
phosphomutant in the NAc core significantly inhibited D2, but not D1 or cocaine-induced 
reinstatement. Interestingly, mice lacking GluR1S845, but not GluR1S831, show deficits in the 
development of LTD (Lee et. al, 2010). Other studies also show that dephosphorylation of 
GluR1S845 is critical for internalization of AMPA receptors in LTD (Lee et. al, 2006, Shepherd 
and Huganir, 2007). Since we hypothesize that D2-induced reinstatement is caused by decreased 
excitability of indirect pathway neurons, expression of the GluR1S845A phosphomutant may 
inhibit the extent to which D2 receptor signaling can cause internalization AMPA receptors, 
thereby blocking the ability of D2 receptors to cause reinstatement. Conversely, since we 
hypothesize that D1-induced reinstatement is driven by increased excitability of direct pathway 
neurons, expression of the GluR1S845A phosphomutant may not inhibit the ability of D1 receptors 
to enhance synaptic AMPA receptors because GluR1S31 is either already involved in this process 
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(Anderson et. al, 2008) or able to compensate for GluR1S845 (Lee et. al, 2010). A lack of full 
compensation might explain why GluR1S845A expression produced a nonsignificant decrease in 
D1-induced reinstatement.  However, it is difficult to explain why expression of GluR1S845A had 
no effect on cocaine-induced reinstatement. It is also difficult to determine how much 
GluR1S845A is present in the NAc core relative to endogenous GluR1, and the extent to which 
GluR1S845A is actually incorporated into functional AMPA receptors. The lack of cell-type 
specificity in the expression of GluR1S845A further complicates interpretation of these results. 
Future studies using viral constructs whose expression is driven by D1 or D2 promoters may 
provide a more elegant experimental strategy to test our hypotheses about the role of GluR1S845 
in direct and indirect pathway MSNs. 
While our results strongly suggest that the behavioral and biochemical effects of adenosine 
receptor stimulation in the NAc are mediated by postsynaptic receptors on MSNs, it is possible 
that A1 and A2A present on presynaptic glutamate terminals may play a role in our findings.  The 
majority of these presynaptic glutamate terminals expressing both A1 and A2A receptors project 
onto direct pathway neurons (Ciruela et. al, 2006, Hettinger et. al, 2001, Orru et. al, 2011a), 
therefore enabling adenosine to regulate glutamate release and subsequent activation of the direct 
pathway (Ferre et. al, 2008, Rodrigues et. al, 2005, Orru et. al, 2011b). Stimulation of 
presynaptic A2A receptors increases glutamate release onto direct pathway neurons and enhances 
their activity (Ciruela et. al, 2006, Corsi et. al, 1999, 2000). Since both of these events are known 
to induce reinstatement (Bachtell et. al, 2008, Cornish and Kalivas, 2000), it seems unlikely that 
presynaptic A2A receptors play a significant role in our experiments. Stimulation of presynaptic 
A1 receptors, however, decreases glutamate release and decreases the activation of the direct 
pathway (Ciruela et. al, 2006, Corsi et. al, 1999, 2000). Both of these actions would presumably 
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inhibit D1-induced reinstatement (Self et. al, 1996, Bachtell et, al, 2008a, 2008b, unpublished 
observations).  Although our phosphorylation data strongly suggest a postsynaptic site of action, 
it is possible that intra-NAc infusion of the A1 agonist CPA may simultaneously inhibit both 
presynaptic glutamate release and postsynaptic D1 signaling. Recent studies have identified an 
A2A receptor antagonist that selectively targets presynaptic receptors, thereby inhibiting 
glutamate release and direct pathway activation without targeting postsynaptic A2A receptors 
(Ferre et. al, 2008). Future studies using this compound will help clarify whether presynaptically 
mediated inhibition of glutamate release plays a significant role in the A1 agonist-mediated 
reversal of D1-induced reinstatement. 
Collectively, our results suggest that adenosine receptors act in a cell-specific manner to 
oppose striatal dopamine receptor signaling that drives expression of cocaine sensitization and 
reinstatement of drug seeking. Specifically, we demonstrate that stimulation of adenosine A1 or 
A2A receptors in the NAc core is sufficient to offset D1 or D2-induced cocaine seeking, 
respectively. These effects may be dependent upon dopamine and adenosine receptors’ opposing 
actions on GluR1 phosphorylation that regulates AMPA receptor trafficking and cellular 
excitability within direct and indirect pathway neurons. Our findings also provide further 
evidence that adenosine receptors are critical regulators of dopamine receptor signaling in 
diseases involving dysregulation of the basal ganglia and/or dopamine pathways. Finally, the 
results of these studies illuminate the potential for adenosine receptor stimulation as an effective 
strategy for reversing cocaine-induced alterations in striatal signaling that may underlie an 
addicts’ persistent susceptibility to relapse. Future research will provide further insight into the 
complex interactions between glutamate, dopamine, and adenosine signaling in the striatum. This 
work may eventually lead to the development of novel strategies to restore balance in striatal 
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output pathways, which will provide relief to millions of patients suffering from neurological 
diseases that currently remain untreatable. 
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